Key Takeaways
- • TFP Fertility Group, a UK and Poland fertility provider backed by Amulet Capital Partners, announced the acquisition of Manchester Fertility Group, an established UK fertility provider; financial terms were not disclosed.
- • Manchester Fertility Group, operating since 1986 from a purpose-built clinic and laboratory in Cheadle, Greater Manchester, brings five brands: Manchester Fertility, Essential Fertility, Semovo, Egg Donors UK and BuySperm.
- • The deal expands TFP's UK operations and its presence in northwest England, combining complementary clinical capabilities and geographic footprints.
- • Amulet Capital Partners, a healthcare-focused middle-market private equity firm managing approximately $3.8 billion in Regulatory AUM (as of September 4, 2026) and investing out of its third fund, frames the deal as a realization of its strategic vision for TFP.
- • TFP was advised by Lincoln International and McDermott Will & Schulte; Manchester Fertility Group was advised by Clearwater International and Weightmans LLP.
Summary
TFP Fertility Group, a leading fertility care provider in the UK and Poland backed by Amulet Capital Partners, has announced the acquisition of Manchester Fertility Group, an established UK fertility treatment provider, according to a company announcement distributed via Business Wire. Financial terms of the transaction were not disclosed.
Manchester Fertility Group has provided fertility care since 1986. The group operates a purpose-built fertility clinic and laboratory in Cheadle, Greater Manchester, and comprises five brands: Manchester Fertility, Essential Fertility, Semovo, Egg Donors UK and BuySperm. Together, these businesses offer treatment, preservation and donor services to patients and partner clinics across the UK.
The acquisition expands TFP's UK operations and its presence in northwest England. The companies describe the combination as bringing together two established providers with complementary clinical capabilities and a broader geographic footprint, which they say will expand access to fertility care across the UK and create a stronger platform for growth.
Jude Fleming, Group Chief Executive Officer of TFP Fertility Group, said Manchester Fertility has built an excellent reputation supported by an experienced team and a commitment to patients, and that the two businesses share a focus on clinical excellence and patient-centred care. Debbie Falconer and Jonathan Koslover, shareholders of Manchester Fertility Group, said they believe they have found a long-term home for the business in TFP. Sam Brinkley, Partner at Amulet Capital Partners, said the firm identified Manchester Fertility as a strong strategic fit and sees significant opportunities to keep investing in TFP's mission across the UK and select European markets.
TFP and Amulet were advised by Lincoln International and McDermott Will & Schulte. Manchester Fertility Group was advised by Clearwater International and Weightmans LLP. Amulet is a middle-market private equity firm focused exclusively on healthcare, with offices in Greenwich, CT, and Walnut Creek, CA.
Manchester Fertility Group has provided fertility care since 1986. The group operates a purpose-built fertility clinic and laboratory in Cheadle, Greater Manchester, and comprises five brands: Manchester Fertility, Essential Fertility, Semovo, Egg Donors UK and BuySperm. Together, these businesses offer treatment, preservation and donor services to patients and partner clinics across the UK.
The acquisition expands TFP's UK operations and its presence in northwest England. The companies describe the combination as bringing together two established providers with complementary clinical capabilities and a broader geographic footprint, which they say will expand access to fertility care across the UK and create a stronger platform for growth.
Jude Fleming, Group Chief Executive Officer of TFP Fertility Group, said Manchester Fertility has built an excellent reputation supported by an experienced team and a commitment to patients, and that the two businesses share a focus on clinical excellence and patient-centred care. Debbie Falconer and Jonathan Koslover, shareholders of Manchester Fertility Group, said they believe they have found a long-term home for the business in TFP. Sam Brinkley, Partner at Amulet Capital Partners, said the firm identified Manchester Fertility as a strong strategic fit and sees significant opportunities to keep investing in TFP's mission across the UK and select European markets.
TFP and Amulet were advised by Lincoln International and McDermott Will & Schulte. Manchester Fertility Group was advised by Clearwater International and Weightmans LLP. Amulet is a middle-market private equity firm focused exclusively on healthcare, with offices in Greenwich, CT, and Walnut Creek, CA.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.